Enochian Biosciences Inc (ENOB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENOB | MRNA | BMY | AMGN | GILD |
| Company | Enochian Biosciences Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7300 | 102.53 | 47.93 | 265.64 | 67.01 |
| High | 0.7500 | 103.50 | 48.41 | 265.92 | 67.02 |
| Low | 0.7000 | 99.90 | 47.62 | 262.58 | 65.90 |
| Last | 0.7000 | 102.00 | 48.30 | 262.75 | 66.16 |
| Change | unch | -1.44 | +0.46 | -1.32 | -0.77 |
| % Change | unch | -1.39% | +0.96% | -0.50% | -1.15% |
| Volume | 88,300 | 1,796,600 | 10,917,169 | 2,082,600 | 6,440,700 |
| 20-Day Average Volume | 436,705 | 3,243,055 | 11,419,520 | 2,201,895 | 6,214,835 |
| Previous Close | 0.7000 | 103.44 | 47.84 | 264.07 | 66.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5940 | 105.46 | 50.99 | 272.96 | 70.21 |
| 20-Day Raw Stochastic | 79.27% | 26.47% | 9.92% | 0.65% | 3.10% |
| 20-Day Relative Strength | 54.14% | 48.81% | 37.48% | 36.64% | 27.91% |
| Weighted Alpha | -71.44 | -19.77 | -30.16 | +4.25 | -25.27 |
| Today's Opinion | 64% Sell | 72% Buy | 72% Sell | 56% Sell | 100% Sell |
| Previous Opinion | 64% Sell | 72% Buy | 56% Sell | 56% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 56% Buy | 24% Sell | 8% Sell | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.68% since 07/28/23 | -4.68% since 04/11/24 | -1.67% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 |
| Low | 0.5700 on 07/31/23 | 99.90 on 04/18/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 |
| High | 0.7638 on 08/01/23 | 107.88 on 04/12/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 |
| 1-Month | |||||
| %Chg | +39.05% since 07/03/23 | -2.17% since 03/18/24 | -6.38% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 |
| Low | 0.4210 on 07/06/23 | 97.00 on 04/03/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 |
| High | 0.7638 on 08/01/23 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | -42.15% since 05/04/23 | +2.96% since 01/18/24 | -3.57% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 |
| Low | 0.3928 on 06/29/23 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 |
| High | 1.2800 on 05/05/23 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| 6-Month | |||||
| %Chg | -36.36% since 02/03/23 | +18.59% since 10/18/23 | -15.04% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 |
| Low | 0.3928 on 06/29/23 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 |
| High | 1.3300 on 04/19/23 | 115.97 on 01/08/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,799 | 39,605,108 | 96,960,152 | 141,520,144 | 83,333,008 |
| Shares Outstanding, K | 58,284 | 382,880 | 2,026,759 | 535,919 | 1,245,077 |
| Annual Sales | 0 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -113,430,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -4,330,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.09 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 05/12/23 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 08/11/23 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.43 | 14.24 | 10.02 |